Aveni
Early-stage Edinburgh
Builds NLP and large-language-model products for compliance, wealth management and AI agent assurance in financial services. Headquartered in Edinburgh.
Fintech AINatural Language ProcessingGenerative AI
UK AI in AI Safety & Alignment
UK companies and labs working on making AI systems safe and aligned.
Companies (4)
Faculty
Acquired London
Applies AI to decision-making for enterprises and the public sector, including work with the NHS, government departments, and companies across other industries. Founded in 2014, with a research-heavy team, and known for its work on AI safety and evaluation. Headquartered in London.
Enterprise AIData & InfrastructureAI Safety & Alignment
Google DeepMind
Acquired London
Runs one of the world's leading AI research labs, behind breakthroughs including AlphaFold, AlphaGo, and the Gemini family of models. Headquartered in London and part of Google, it anchors much of the UK's AI research base.
ResearchFoundation ModelsAI for Science
Unitary
Early-stage London
Uses multimodal AI to moderate visual content at scale, reading what is in a video or image and the context around it to flag harmful material, combining AI agents with human review. Founded in 2019 by Sasha Haco and James Thewlis. Headquartered in London.
Computer VisionAI Safety & AlignmentEnterprise AI
Latest coverage
Research
UK AI Security Institute launches Control Red Team, finds flaws in every safety monitor it tested at Anthropic and DeepMind
The UK government's AI Security Institute has stood up a dedicated Control Red Team to stress-test the safeguards that frontier labs rely on. It reported finding vulnerabilities in every version of the internal safety monitors used by Anthropic and Google DeepMind, sharpening the UK's role in frontier-AI oversight.
Investment
Isomorphic Labs raises $2.1B to turn AlphaFold into medicines
Isomorphic Labs, the London drug-discovery company spun out of Google DeepMind, has raised $2.1B in its first external round, led by Thrive Capital with backing from Alphabet and GV. The money is meant to carry its AI-designed drugs toward the clinic.